326 related articles for article (PubMed ID: 32232963)
1. Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma.
Powell AGMT; Chin C; Coxon AH; Chalishazar A; Christian A; Roberts SA; Lewis WG
BJS Open; 2020 Jun; 4(3):416-423. PubMed ID: 32232963
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
[TBL] [Abstract][Full Text] [Related]
3. Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer.
Miyamoto Y; Hiyoshi Y; Daitoku N; Okadome K; Sakamoto Y; Yamashita K; Kuroda D; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Baba H
Dis Colon Rectum; 2019 Dec; 62(12):1485-1493. PubMed ID: 31567920
[TBL] [Abstract][Full Text] [Related]
4. Risk Stratification Using Neoadjuvant Rectal Score in the Era of Neoadjuvant Chemoradiotherapy: Validation With Long-term Outcome Data.
Lim YJ; Song C; Jeon SH; Kim K; Chie EK
Dis Colon Rectum; 2021 Jan; 64(1):60-70. PubMed ID: 33306532
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
6. Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.
Kim JM; Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
Dis Colon Rectum; 2020 Jun; 63(6):758-768. PubMed ID: 32384406
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.
Jimenez L; Perez RO; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Habr-Gama A; DeVecchio J; Kalady MF; Camargo AA
Dis Colon Rectum; 2020 Mar; 63(3):300-309. PubMed ID: 31842156
[TBL] [Abstract][Full Text] [Related]
9. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer.
Leijssen LGJ; Dinaux AM; Taylor MS; Deshpande V; Kunitake H; Bordeianou LG; Berger DL
Dis Colon Rectum; 2019 Oct; 62(10):1212-1221. PubMed ID: 31490830
[TBL] [Abstract][Full Text] [Related]
10. Perirenal Fat Surface Area and Oncologic Outcome in Elective Colon Cancer Surgery.
Eckberg SE; Dahlberg MJA; der Hagopian OS; Farahnak P; Sandblom GK; Nordenvall CAM; Everhov ÅH
Dis Colon Rectum; 2021 Feb; 64(2):171-180. PubMed ID: 33315716
[TBL] [Abstract][Full Text] [Related]
11. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy.
Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y
Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533
[TBL] [Abstract][Full Text] [Related]
12. A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer.
Patel SV; Zhang L; Wei XS; Merchant SJ; Nanji S; James PD; Booth CM
Dis Colon Rectum; 2020 Mar; 63(3):336-345. PubMed ID: 32045399
[TBL] [Abstract][Full Text] [Related]
13. Implementation of an Enhanced Recovery Protocol Is Associated With On-Time Initiation of Adjuvant Chemotherapy in Colorectal Cancer.
Hassinger TE; Mehaffey JH; Martin AN; Bauer-Nilsen K; Turrentine FE; Thiele RH; Sarosiek BM; Reilley MJ; Hoang SC; Friel CM; Hedrick TL
Dis Colon Rectum; 2019 Nov; 62(11):1305-1315. PubMed ID: 31567924
[TBL] [Abstract][Full Text] [Related]
14. Definitive Chemoradiation for Rectal Cancer: Is There a Role for Dose Escalation? A National Cancer Database Study.
Wegner RE; Hasan S; Renz PB; Raj MS; Monga DK; Finley GG; Kirichenko AV; McCormick JT
Dis Colon Rectum; 2019 Nov; 62(11):1336-1343. PubMed ID: 31567930
[TBL] [Abstract][Full Text] [Related]
15. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.
Chen PJ; Li TL; Sun TT; Willis VC; Roebuck MC; Bravata DM; Liu XZ; Arriaga YE; Dankwa-Mullan I; Wu AW
Dis Colon Rectum; 2020 Oct; 63(10):1383-1392. PubMed ID: 32969881
[TBL] [Abstract][Full Text] [Related]
16. Association of a Preoperative Leisure-Time Physical Activity With Short- and Long-term Outcomes of Patients Undergoing Curative Resection for Stage I to III Colorectal Cancer: A Propensity Score Matching Analysis.
You JF; Hsu YJ; Chern YJ; Hung HY; Hsieh PS; Yeh CY; Chiang JM; Tsai WS
Dis Colon Rectum; 2020 Jun; 63(6):796-806. PubMed ID: 32118625
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Clinicopathological Characteristics of Appendiceal Tumors in Japan: A Multicenter Collaborative Retrospective Clinical Study- A Japanese Nationwide Survey.
Matsui S; Murata K; Fukunaga Y; Takeda T; Fujii M; Yamaguchi T; Kagawa Y; Mizushima T; Ohno Y; Yao T; Doki Y; Sugihara K
Dis Colon Rectum; 2020 Oct; 63(10):1403-1410. PubMed ID: 32969883
[TBL] [Abstract][Full Text] [Related]
18. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
[TBL] [Abstract][Full Text] [Related]
19. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis.
Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Hase K; Yamamoto J; Ueno H
Dis Colon Rectum; 2019 Nov; 62(11):1316-1325. PubMed ID: 31567925
[TBL] [Abstract][Full Text] [Related]
20. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]